Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARI
2276
Apollo Commercial Real Estate
ARI
$886M
| $3.07M | ﹤0.01% |
321,030
-98,578
| -23% | -$936K |
|
2277
Cadiz
CDZI
$295M
| $3.06M | ﹤0.01% |
1,045,731
+979,007
| +1,467% | +$4.3M |
|
2278
SAP
SAP
$242B
| $3.06M | ﹤0.01% |
11,412
+8,056
| +240% | +$2.19M |
|
2279
Arbor Realty Trust
ABR
$981M
| $3.06M | ﹤0.01% |
260,557
-64,389
| -20% | -$833K |
|
2280
Caleres
CAL
$461M
| $3.06M | ﹤0.01% |
177,527
+117,866
| +198% | +$2.12M |
|
2281
Cadre Holdings
CDRE
$1.45B
| $3.06M | ﹤0.01% |
103,253
+8,555
| +9% | +$295K |
|
2282
Algonquin Power & Utilities
AQN
$4.48B
| $3.05M | ﹤0.01% |
594,068
-58,264
| -9% | -$275K |
|
2283
CRISPR Therapeutics
CRSP
$5.22B
| $3.05M | ﹤0.01% |
89,626
-12,432
| -12% | -$527K |
|
2284
Arcutis Biotherapeutics
ARQT
$3.25B
| $3.05M | ﹤0.01% |
194,772
-43,169
| -18% | -$608K |
|
2285
IDEAYA Biosciences
IDYA
$3.53B
| $3.04M | ﹤0.01% |
185,366
-13,390
| -7% | -$285K |
|
2286
Honda
HMC
$40.5B
| $3.03M | ﹤0.01% |
111,861
+111,280
| +19,153% | +$3.17M |
|
2287
DigitalOcean
DOCN
$15.6B
| $3.03M | ﹤0.01% |
90,688
-32,589
| -26% | -$1.27M |
|
2288
Viasat
VSAT
$11.4B
| $3.03M | ﹤0.01% |
290,541
+70,888
| +32% | +$683K |
|
2289
Pricesmart
PSMT
$5.55B
| $3.02M | ﹤0.01% |
34,372
-12,021
| -26% | -$1.07M |
|
2290
BioCryst Pharmaceuticals
BCRX
$2.51B
| $3.02M | ﹤0.01% |
402,600
-61,646
| -13% | -$497K |
|
2291
BOK Financial
BOKF
$8.85B
| $3.02M | ﹤0.01% |
28,976
-4,682
| -14% | -$503K |
|
2292
Vishay Intertechnology
VSH
$5.11B
| $3.01M | ﹤0.01% |
189,548
-40,784
| -18% | -$699K |
|
2293
Canadian Imperial Bank of Commerce
CM
$112B
| $3.01M | ﹤0.01% |
53,525
+3,640
| +7% | +$220K |
|
2294
Addus HomeCare
ADUS
$2.2B
| $3.01M | ﹤0.01% |
30,472
-32,091
| -51% | -$3.57M |
|
2295
Riot Platforms
RIOT
$7.21B
| $3.01M | ﹤0.01% |
422,308
-135,005
| -24% | -$1.4M |
|
2296
Cellebrite
CLBT
$2.69B
| $2.99M | ﹤0.01% |
154,024
-291,771
| -65% | -$6.14M |
|
2297
Cushman & Wakefield Ltd
CWK
$3.37B
| $2.99M | ﹤0.01% |
292,306
-110,467
| -27% | -$1.34M |
|
|
BAND
2298
Bandwidth Inc
BAND
$1.74B
| $2.98M | ﹤0.01% |
227,354
-2,915
| -1% | -$47.7K |
|
|
B
2299
CALL
Barrick Mining
B
$67.3B
| $2.98M | ﹤0.01% |
153,200
-106,800
| -41% | -$1.87M |
|
2300
CALL
AT&T
T
$168B
| $2.98M | ﹤0.01% |
105,300
-125,600
| -54% | -$3.16M |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.